Tech Company Financing Transactions

IDRx Funding Round

On 8/8/2024, IDRx raised $120 million in Series B investment from Blackstone, Commodore Capital and RA Capital Management.

Transaction Overview

Company Name
Announced On
8/8/2024
Transaction Type
Venture Equity
Amount
$120,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to support the ongoing Phase 1/1b StrateGIST 1 study of its lead product candidate IDRX-42, a potent, oral, highly selective KIT inhibitor targeting all major categories of activating and resistance mutations in patients with KIT-mutant GIST. Additionally, proceeds will be used to fund the expected initiation of the first pivotal study for IDRX-42 in patients with second-line GIST.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
52 Court St.
Plymouth, MA 02360
USA
Phone
Undisclosed
Email Address
Overview
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. Founded in 2022, IDRx's leadership team has extensive experience in drug development, and collectively has been involved in the discovery, development and commercialization of more than 10 approved drugs.
Profile
IDRx LinkedIn Company Profile
Social Media
IDRx Company Twitter Account
Company News
IDRx News
Facebook
IDRx on Facebook
YouTube
IDRx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ben Auspitz
  Ben Auspitz LinkedIn Profile  Ben Auspitz Twitter Account  Ben Auspitz News  Ben Auspitz on Facebook
Chief Operating Officer
Jessica Christo
  Jessica Christo LinkedIn Profile  Jessica Christo Twitter Account  Jessica Christo News  Jessica Christo on Facebook
VP - Operations
Debbie Johnson
  Debbie Johnson LinkedIn Profile  Debbie Johnson Twitter Account  Debbie Johnson News  Debbie Johnson on Facebook
VP - Product Management
Vic Kadambi
  Vic Kadambi LinkedIn Profile  Vic Kadambi Twitter Account  Vic Kadambi News  Vic Kadambi on Facebook
VP - Regulatory Affairs
Shrenik Desai
  Shrenik Desai LinkedIn Profile  Shrenik Desai Twitter Account  Shrenik Desai News  Shrenik Desai on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/8/2024: CloudPay venture capital transaction
Next: 8/8/2024: Prana Thoracic venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary